Provision of Spironolactone and Placebo for Clinical trials
The University of Southampton is looking for a company to procure, re-package, label, store & distribute a drug to 5 health care sites across England. The requirement is for use in a multicentre double-blind randomised superiority trial to investigate the clinical and cost-effectiveness of spironolactone in the treatment of moderate-severe persistent acne in adult women compared to placebo, in addition to standard treatment. The two equal arms are as follows: o Oral spironolactone 50 mg/100mg once daily for 24 week...
Buyer
UNIVERSITY OF SOUTHAMPTON
Value
£117,000
Published
23 Feb 2018
Closes
14 Mar 2018
Procurement details
Source
Contracts Finder
Region
Southampton
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33630000
Medicinal products for dermatology and the musculo-skeletal system
Lots
Lot default Provision of Spironolactone and Placebo for Clinical trials
£117,000
The University of Southampton is looking for a company to procure, re-package, label, store & distribute a drug to 5 health care sites across England. The requirement is for use in a multicentre double-blind randomised superiority trial to investigate the clinical and cost-effectiveness of spironolactone in the treatment of moderate-severe persistent acne in...
Delivery: South East · United Kingdom, South East, United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
23 Feb 2018
Opportunity notice on Contracts Finder
Tender notice · Web page
Additional information on how to apply for this contract
Not provided
Additional information on how to apply for this contract
Tender notice
Contains public sector information licensed under the Open Government Licence v3.0.